|Bid||150.92 x 1300|
|Ask||151.09 x 900|
|Day's range||150.22 - 151.95|
|52-week range||122.18 - 165.35|
|Beta (5Y monthly)||0.42|
|PE ratio (TTM)||26.16|
|Forward dividend & yield||3.65 (2.45%)|
|Ex-dividend date||20 Oct 2022|
|1y target est||N/A|
Procter & Gamble (NYSE: PG) isn't the first stock you'd think of when naming risky investments. The consumer staples giant has been consistently profitable for decades, and its massive global selling footprint makes it among the most stable businesses around.
With the Nasdaq Composite still firmly entrenched in bear market territory, if you're feeling discouraged about the state of your portfolio and the performance of some of your favorite stocks, you're certainly not alone. Two stocks that in my view belong firmly in the former category are DexCom (NASDAQ: DXCM) and Procter & Gamble (NYSE: PG). If you're searching for a non-cyclical company with products that are consistently in demand, regardless of the macro environment or consumer sentiment, DexCom could be a no-brainer contender for your portfolio.
Procter & Gamble (PG) closed at $150.24 in the latest trading session, marking a +0.64% move from the prior day.